These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19666837)

  • 21. Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells.
    Zhang L; Peppel K; Brian L; Chien L; Freedman NJ
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2277-83. PubMed ID: 15486311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology of vein graft failure: a review.
    Davies MG; Hagen PO
    Eur J Vasc Endovasc Surg; 1995 Jan; 9(1):7-18. PubMed ID: 7664016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extravascular perivenous fibrin support leads to aneurysmal degeneration and intimal hyperplasia in arterialized vein grafts in the rat.
    Stojanovic T; El-Sayed Ahmad A; Didilis V; Ali O; Popov AF; Danner BC; Seipelt R; Dörge H; Schöndube FA
    Langenbecks Arch Surg; 2009 Mar; 394(2):357-62. PubMed ID: 18509670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-beta1 antisense treatment of rat vein grafts reduces the accumulation of collagen and increases the accumulation of h-caldesmon.
    Wolff RA; Malinowski RL; Heaton NS; Hullett DA; Hoch JR
    J Vasc Surg; 2006 May; 43(5):1028-36. PubMed ID: 16678700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1.
    Wolff RA; Ryomoto M; Stark VE; Malinowski R; Tomas JJ; Stinauer MA; Hullett DA; Hoch JR
    J Vasc Surg; 2005 Mar; 41(3):498-508. PubMed ID: 15838486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vein graft neointimal hyperplasia: prevention is better than cure.
    Rosenfeldt F; He GW; Roubos N
    J Thorac Cardiovasc Surg; 2007 Apr; 133(4):1118; author reply 1119. PubMed ID: 17382675
    [No Abstract]   [Full Text] [Related]  

  • 27. Origin of neointimal cells in autologous vein graft.
    Sata M; Nagai R
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1147-9. PubMed ID: 15237090
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts.
    Misra S; Fu AA; Puggioni A; Karimi KM; Mandrekar JN; Glockner JF; Juncos LA; Anwer B; McGuire AM; Mukhopadhyay D
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2219-30. PubMed ID: 18326810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mathematical model of venous neointimal hyperplasia formation.
    Budu-Grajdeanu P; Schugart RC; Friedman A; Valentine C; Agarwal AK; Rovin BH
    Theor Biol Med Model; 2008 Jan; 5():2. PubMed ID: 18215280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slower onset of low shear stress leads to less neointimal thickening in experimental vein grafts.
    Baldwin ZK; Chandiwal A; Huang W; Vosicky JE; Balasubramanian V; Curi MA; Schwartz LB
    Ann Vasc Surg; 2006 Jan; 20(1):106-13. PubMed ID: 16374533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vein quality in vascular surgery.
    Stansby G
    Lancet; 1998 Apr; 351(9108):1001-2. PubMed ID: 9546500
    [No Abstract]   [Full Text] [Related]  

  • 32. Transfected early growth response gene-1 DNA enzyme prevents stenosis and occlusion of autogenous vein graft in vivo.
    Liu C; Zhang X; Wang S; Cheng M; Liu C; Wang S; Hu X; Zhang Q
    Biomed Res Int; 2013; 2013():310406. PubMed ID: 23586030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
    Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice.
    Yamamoto K; Onoda K; Sawada Y; Fujinaga K; Imanaka-Yoshida K; Shimpo H; Yoshida T; Yada I
    Cardiovasc Res; 2005 Feb; 65(3):737-42. PubMed ID: 15664401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The "blue-toe" syndrome as a harbinger of impending infrainguinal vein graft failure: a report of three cases.
    Fujitani RM; Mills JL; Taylor SM
    Ann Vasc Surg; 1993 Jul; 7(4):330-5. PubMed ID: 8268072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model.
    Zhang L; Hagen PO; Kisslo J; Peppel K; Freedman NJ
    J Vasc Surg; 2002 Oct; 36(4):824-32. PubMed ID: 12368745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenovirus-mediated gene transfer of fibromodulin inhibits neointimal hyperplasia in an organ culture model of human saphenous vein graft disease.
    Ranjzad P; Salem HK; Kingston PA
    Gene Ther; 2009 Sep; 16(9):1154-62. PubMed ID: 19474808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis.
    Kenagy RD; Fukai N; Min SK; Jalikis F; Kohler TR; Clowes AW
    J Vasc Surg; 2009 May; 49(5):1282-8. PubMed ID: 19307078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MMP inhibition reduces intimal hyperplasia in a human vein graft stenosis model.
    Loftus IM; Porter K; Peterson M; Boyle J; London NJ; Bell PR; Thompson MM
    Ann N Y Acad Sci; 1999 Jun; 878():547-50. PubMed ID: 10415769
    [No Abstract]   [Full Text] [Related]  

  • 40. Gene therapy for vein graft disease.
    Cable DG; Schaff HV
    Curr Cardiol Rep; 2001 Jan; 3(1):22-8. PubMed ID: 11139795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.